Von willebrand factor antigen identifies high-risk hepatocellular cancer patients prior to liver resection who might benefit from liver transplantation instead
Year: 2024
Type: article
Study design: Observational Study
Source: HPB
Authors: D. Pereyra, A.E. Kern, J. Dingfelder, S. Kacar, N. Becker, L. Gregory, A. Mullan, J. Santol, T. Gruenberger, R. Smoot, S. Cleary, M. Truty, S. Warner, C. Thiels, M. Kendrick, P. Kamath, G. Berlakovich, J. Heimbach, G. Gyoeri, P. Starlinger
Institutions: Medical University of Vienna, Mayo Clinic
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4396961906